WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924004443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849330239610552320 |
|---|---|
| author | Hiddo J.L. Heerspink David C. Wheeler Ricardo Correa-Rotter Jamie P. Dwyer Anna Maria Langkilde Patrick B. Mark Michal Nowicki Peter Rossing Robert D. Toto Glenn M. Chertow Niels Jongs |
| author_facet | Hiddo J.L. Heerspink David C. Wheeler Ricardo Correa-Rotter Jamie P. Dwyer Anna Maria Langkilde Patrick B. Mark Michal Nowicki Peter Rossing Robert D. Toto Glenn M. Chertow Niels Jongs |
| author_sort | Hiddo J.L. Heerspink |
| collection | DOAJ |
| format | Article |
| id | doaj-art-71c72a9cd21647ffb715f3a53e83d342 |
| institution | Kabale University |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-71c72a9cd21647ffb715f3a53e83d3422025-08-20T03:47:01ZengElsevierKidney International Reports2468-02492024-04-0194S17310.1016/j.ekir.2024.02.355WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHYHiddo J.L. Heerspink0David C. Wheeler1Ricardo Correa-Rotter2Jamie P. Dwyer3Anna Maria Langkilde4Patrick B. Mark5Michal Nowicki6Peter Rossing7Robert D. Toto8Glenn M. Chertow9Niels Jongs10Groningen, Department of Clinical Pharmacy and Pharmacology, NetherlandsDepartment of Renal Medicine, University College London, LondonDepartment of Nephrology and Mineral Metabolism, The National Medical Science and Nutrition Institute Salvador Zubiran, Mexico cityDivision of Nephrology and Hypertension, University of Utah, Salt Lake CityBioPharmaceuticals R&D, AstraZeneca, GothenburgSchool of Cardiovascular and Metabolic Health / Renal & Transplant Unit, University of Glasgow / Queen Elizabeth University Hospital, GlasgowDepartment of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, LodzDepartment of Clinical Medicine, University of Copenhagen / Steno Diabetes Center Copenhagen, Gentofte / CopenhagenDepartment of Internal Medicine, UT Southwestern Medical Center, DallasDepartments of Medicine and Epidemiology and Population, Stanford University, StanfordDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, Groningenhttp://www.sciencedirect.com/science/article/pii/S2468024924004443 |
| spellingShingle | Hiddo J.L. Heerspink David C. Wheeler Ricardo Correa-Rotter Jamie P. Dwyer Anna Maria Langkilde Patrick B. Mark Michal Nowicki Peter Rossing Robert D. Toto Glenn M. Chertow Niels Jongs WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY Kidney International Reports |
| title | WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY |
| title_full | WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY |
| title_fullStr | WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY |
| title_full_unstemmed | WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY |
| title_short | WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY |
| title_sort | wcn24 1766 effects of dapagliflozin in patients with membranous nephropathy |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924004443 |
| work_keys_str_mv | AT hiddojlheerspink wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT davidcwheeler wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT ricardocorrearotter wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT jamiepdwyer wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT annamarialangkilde wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT patrickbmark wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT michalnowicki wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT peterrossing wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT robertdtoto wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT glennmchertow wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy AT nielsjongs wcn241766effectsofdapagliflozininpatientswithmembranousnephropathy |